Protzer_Lab
@ProtzerLab
Followers
342
Following
582
Statuses
99
Research group at @TU_Muenchen and @HelmholtzMunich focused on HBV immunotherapy and emerging viral infections. Tweets by group members.
Munich, Germany
Joined September 2022
RT @erturklab: LNP/mRNA therapeutics and AAV-based approaches require cell-level precision to achieve success without significant toxicity…
0
75
0
RT @hendrik_dietz: Very excited that this study led by @erturklab is finally out. Among deep insight into in vivo distribution of LNP and A…
0
129
0
Our new research reveals SARS-CoV-2 doesn't just stop at the lungs—it infects liver cells, replicates, and induces cell death. A deeper dive into the virus's stealthy tactics and its role in liver damage during COVID-19. #Virology #COVID19Research 🦠🧪🧑��
0
4
11
RT @KnolleLab: We are proud to host the GASL Annual Meeting 2025 from 14-15 February in Munich. The GASL program with fanatastic talks and…
0
3
0
RT @TherVacB_EU: Working on advanced #antiviral strategies, #biomedical engineering and #therapeutic approaches to combat viral #infections…
0
2
0
RT @virofight: 🎉Speaker Announcement🎉 We’re excited to welcome Alba Monferrer from CPTx to the #VirofightSymposium! CPTx's innovative plat…
0
2
0
RT @Baldauf_Lab: The last day of the #immunobiology of viral infections #workshop was scientifically concluded by Dr. Anna Kosinska @TU_Mue…
0
2
0
RT @virofight: Why you should attend #VIROFIGHTSymposium24❔ 💡We'll showcase the latest results & achievements of our VIROFIGHT project, hi…
0
1
0
RT @NobelPrize: BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the disc…
0
12K
0
RT @ljpally19: Along with Laura @DrLauraWolz & Laura @CarterL_J (Laura x3) we have co-founded Carers in STEMM to provide a platform to impr…
0
22
0
RT @FrontImmunol: Congratulations to Sophia Schreiber (@ProtzerLab) and Lisa S. Dessler (@TU_Muenchen) for winning the #PaperOfTheQuarter a…
0
2
0
RT @DGGTeV: The #DGGTeV is delighted to present Sophia Schreiber and Lisa S. Dessler from @ProtzerLab at the @TU_Muenchen the #PaperoftheQu…
0
1
0
Explore how bispecific T-cell engager antibodies revolutionize chronic hepatitis B treatment by activating adaptive immunity. Read about the promising strategy in the fight against HBV in our latest review by @zhexie97 and @UlrikeProtzer!
0
1
7
RT @GesVirologie: 23rd workshop of the #jGfV study group "Immunobiology to viral infection" 28.-30.10.24 in Bad Salzschlirf. Deadline Septe…
0
7
0
RT @grimmlab: Happy that our joint article with Ulrike Protzer's lab (@ProtzerLab) on the use of AAV vectors for development of HBV mouse m…
0
2
0
NTCP is a limiting factor for HBV infection in porcine hepatocytes, with amino acids 158 and 167 in porcine NTCP inhibiting the interaction with the virus. These findings pave the way for the development of transgenic pigs as new models for HBV research 🎉🍾
0
0
1
RT @KBoettcherLab: 📣We are looking for a PhD student to join the team! 📣 If you are interested in unravelling the role of innate-like MAIT…
0
16
0
RT @JHEP_Reports: 🟪NEW Article in press❕ HBV-related #HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx…
0
2
0
Do not miss the Best Poster Presentation Award winner at #EASLCongress 2024! 🏆Come and visit Zhe Xie’s incredible work in the poster area TOP-355-YI! 🤩🎉👏🏻👍
1
1
12